Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-19 | Mr. Burns has more than 25 years of direct ophthalmic management experience and received a B.A. from Yale University. |
| 2017-04-18 | Mr. Burns has more than 25 years of direct ophthalmic management experience, including over 20 years of general management experience across a broad range of ophthalmic medical devices, ophthalmic pharmaceuticals, drug delivery technologies, surgical products and over-the-counter products. Mr. Burns received a B.A. from Yale University. |
| 2018-04-18 | Mr. Burns has a proven record of building successful medical device and pharmaceutical businesses and creating successful new markets in ophthalmology. Mr. Burns has more than 25 years of direct ophthalmic management experience, including over 20 years of general management experience across a broad range of ophthalmic medical devices, ophthalmic pharmaceuticals, drug delivery technologies, surgical products and over-the-counter products. Prior to joining our Company, Mr. Burns led Eyetech Pharmaceuticals, Inc. (acquired by OSI Pharmaceuticals, Inc.) as its president and chief operating officer, and as a director. |
| 2019-04-17 | Mr. Burns received a B.A. from Yale University. |
| 2020-04-24 | Mr. Burns received a B.A. from Yale University. We believe Mr. Burns’ extensive understanding of our business, operations and strategy, as well as significant industry experience and corporate management skills and experience, qualify him to serve on our Board of Directors. |
| 2021-04-22 | Mr. Burns has more than 25 years of direct ophthalmic management experience, including over 20 years of general management experience across a broad range of ophthalmic medical devices and pharmaceuticals, drug delivery technologies, surgical products and over-the-counter products. |
| 2022-04-19 | Mr. Burns has more than 25 years of direct ophthalmic management experience ... Mr. Burns received a B.A. from Yale University. |
| 2023-04-18 | Chief Executive Officer and Board Member, Glaukos Corporation (2002 to current); Chairman of the Board (2021 to current); Bachelor of Arts, Yale University; no mention of technical or software skills. |
| 2024-04-16 | Chief Executive Officer and Board Member, Glaukos Corporation (2002 to current); Chairman of the Board (2021 to current); Bachelor of Arts, Yale University; Proven record of building successful medical device and pharmaceutical businesses. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-09 | Thomas W. Burns, age 60, has served as a member of our Board of Directors since September 2020... The Compensation Committee is composed of three directors: Messrs. Burns, Ferrari, and Florin... Thomas W. Burns X ... Total 253,431 |
| 2022-04-15 | Thomas W. Burns, age 61, has served as a member of our Board since September 2020... Mr. Burns is independent... Thomas W. Burns | X ... Fees Earned or Paid in Cash 49,682; Stock Awards 121,954; Total 171,636. |
| 2023-04-04 | Thomas W. Burns, age 62, has served as a member of our Board since September 2020. Since December 2021, Mr. Burns has served as Chairman of the Board and Chief Executive Officer of Glaukos Corporation... Thomas W. Burns | Fees Earned or Paid in Cash $47,500 | Stock Awards $98,784 | Total $146,284 |
| 2024-04-05 | Thomas W. Burns, age 63, has served as a member of our Board since September 2020. Since December 2021, Mr. Burns has served as Chairman of the Board and Chief Executive Officer of Glaukos Corporation... The following table provides membership... Thomas W. Burns ... Compensation X |
| 2025-04-08 | Thomas W. Burns, age 64, has served as a member of our Board since September 2020... The following table provides membership... Thomas W. Burns | X ... Non-Employee Director Compensation... Thomas W. Burns 52,500 104,990 157,490 |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-06